(Q40297687)

English

Increased sensitivity to the platelet-derived growth factor (PDGF) receptor inhibitor STI571 in chemoresistant glioma cells is associated with enhanced PDGF-BB-mediated signaling and STI571-induced Akt inactivation

scientific article published on July 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 September 2017

Increased sensitivity to the platelet-derived growth factor (PDGF) receptor inhibitor STI571 in chemoresistant glioma cells is associated with enhanced PDGF-BB-mediated signaling and STI571-induced Akt inactivation (English)

1 reference

Europe PubMed Central

19 September 2017

1 reference

based on heuristic

inferred from title

Maurizio Sanguinetti

3

1 reference

Europe PubMed Central

19 September 2017

Riccardo Riccardi

object named as

Riccardo Riccardi

5

0 references

author name string

Tiziana Servidei

1

1 reference

Europe PubMed Central

19 September 2017

Anna Riccardi

2

1 reference

Europe PubMed Central

19 September 2017

Carlo Dominici

4

1 reference

Europe PubMed Central

19 September 2017

publication date

1 July 2006

1 reference

Europe PubMed Central

19 September 2017

Journal of Cellular Physiology

1 reference

Europe PubMed Central

19 September 2017

208

1 reference

Europe PubMed Central

19 September 2017

220-228

1 reference

Europe PubMed Central

19 September 2017

1

1 reference

Europe PubMed Central

19 September 2017

State-of-the-art treatment of high-grade brain tumors

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20659

21 January 2018

BCR/ABL kinase inhibition by imatinib mesylate enhances MAP kinase activity in chronic myelogenous leukemia CD34+ cells

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20659

21 January 2018

Enhanced sensitivity to the HER1/epidermal growth factor receptor tyrosine kinase inhibitor erlotinib hydrochloride in chemotherapy-resistant tumor cell lines.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20659

21 January 2018

Specific targeted therapy of chronic myelogenous leukemia with imatinib

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20659

21 January 2018

Imatinib and hydroxyurea in pretreated progressive glioblastoma multiforme: a patient series.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20659

21 January 2018

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20659

21 January 2018

ErbB-3 mediates phosphoinositide 3-kinase activity in gefitinib-sensitive non-small cell lung cancer cell lines

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20659

21 January 2018

The PDGF family: four gene products form five dimeric isoforms

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20659

21 January 2018

Chronic Myeloid Leukemia — Advances in Biology and New Approaches to Treatment

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20659

21 January 2018

Platelet-derived growth factor-B enhances glioma angiogenesis by stimulating vascular endothelial growth factor expression in tumor endothelia and by promoting pericyte recruitment

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20659

21 January 2018

Management of malignant gastrointestinal stromal tumours

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20659

21 January 2018

Induction of heparin-binding EGF-like growth factor and activation of EGF receptor in imatinib mesylate-treated squamous carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20659

21 January 2018

Malignant glioma: genetics and biology of a grave matter.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20659

21 January 2018

Imatinib mesylate (Gleevec) inhibits ovarian cancer cell growth through a mechanism dependent on platelet-derived growth factor receptor alpha and Akt inactivation

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20659

21 January 2018

A novel method to compensate for different amplification efficiencies between patient DNA samples in quantitative real-time PCR.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20659

21 January 2018

Drug resistance of human glioblastoma cells conferred by a tumor-specific mutant epidermal growth factor receptor through modulation of Bcl-XL and caspase-3-like proteases

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20659

21 January 2018

Molecular neuro-oncology and development of targeted therapeutic strategies for brain tumors. Part 1: growth factor and Ras signaling pathways

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20659

21 January 2018

Experimental validation of novel and conventional approaches to quantitative real-time PCR data analysis

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20659

21 January 2018

A new mathematical model for relative quantification in real-time RT-PCR

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20659

21 January 2018

Apoptosis defects and chemotherapy resistance: molecular interaction maps and networks

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20659

21 January 2018

The novel trinuclear platinum complex BBR3464 induces a cellular response different from cisplatin.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20659

21 January 2018

Dominant-negative mutants of platelet-derived growth factor revert the transformed phenotype of human astrocytoma cells

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20659

21 January 2018

Dose-dependent effects of platelet-derived growth factor-B on glial tumorigenesis

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20659

21 January 2018

Cisplatin: mode of cytotoxic action and molecular basis of resistance

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20659

21 January 2018

Effect of receptor kinase inactivation on the rate of internalization and degradation of PDGF and the PDGF beta-receptor

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20659

21 January 2018

c-Kit is preferentially expressed in MYCN-amplified neuroblastoma and its effect on cell proliferation is inhibited in vitro by STI-571.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20659

21 January 2018

Activation of the PI3K/Akt pathway and chemotherapeutic resistance

1 reference

https://api.crossref.org/works/10.1002%2FJCP.20659

21 January 2018

Identifiers

10.1002/JCP.20659

1 reference

Europe PubMed Central

19 September 2017

release_xspdrg2c4rddhn2hoqngwph5yu

1 reference

https://api.fatcat.wiki/v0/release/xspdrg2c4rddhn2hoqngwph5yu

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

19 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40297687&oldid=1894183201"